Thermo Fisher Scientific Stock-Based Comp increased by 20.0% to $84.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $79.00M to $84.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 7.7% CAGR.
An increase may signal a strategy to retain talent without using cash, but it also indicates future dilution for existing shareholders.
The value of equity-based awards granted to employees as part of their compensation package, recognized as an expense on...
High-growth software companies often have high SBC as a percentage of operating cash flow compared to mature industrial firms.
cf_stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.00M | $51.00M | $77.00M | $78.00M | $77.00M | $77.00M | $75.00M | $76.00M | $74.00M | $67.00M | $61.00M | $70.00M | $84.00M | $68.00M | $79.00M | $75.00M | $81.00M | $70.00M | $84.00M |
| QoQ Change | — | +0.0% | +51.0% | +1.3% | -1.3% | +0.0% | -2.6% | +1.3% | -2.6% | -9.5% | -9.0% | +14.8% | +20.0% | -19.0% | +16.2% | -5.1% | +8.0% | -13.6% | +20.0% |
| YoY Change | — | — | — | — | +51.0% | +51.0% | -2.6% | -2.6% | -3.9% | -13.0% | -18.7% | -7.9% | +13.5% | +1.5% | +29.5% | +7.1% | -3.6% | +2.9% | +6.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.